Cover Image
市場調查報告書

亞洲的醫藥品、醫療產業 (季度更新報告)

Asia Pharmaceuticals and Healthcare Report Q4 2016

出版商 BMI Research 商品編碼 363588
出版日期 內容資訊 英文 39 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞洲的醫藥品、醫療產業 (季度更新報告) Asia Pharmaceuticals and Healthcare Report Q4 2016
出版日期: 2016年10月26日 內容資訊: 英文 39 Pages
簡介

本報告提供亞洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 亞洲市場最新形勢

SWOT分析

  • 亞洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 亞洲:風險/利潤指標

市場概況

  • 亞洲市場最新形勢

產業的趨勢與發展

  • 亞洲市場最新形勢

域內市場概況

  • 亞洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1016

BMI View: Private healthcare providers will become a central part of Asia's medical landscape. Galvanised by the growing demand for medical services across the region and the shortfall in supply from public facilities, these firms are expected to expand their presence steadily over the coming years. These companies can be categorised into two broad groups: regional healthcare providers such as Raffles Medical Group and more domestic-focused firms such as Siloam International Hospital. This trend will shape the flow of patients, with commercial implications for pharmaceutical sales. It can also serve as a source of competition should domestic drugmakers diversify into medical provision.

Healthcare Expenditure Forecasts:

  • Pharmaceuticals: USD282bn in 2015 to USD304bn by 2016; 8.1% y-o-y increase in US dollar terms.
  • Healthcare: USD1,576bn in 2015 to USD1,699bn by 2016; a 7.8% y-o-y increase in US dollar terms.

Risk/Reward Index

In BMI's Pharmaceutical Q416 Risk/Reward Index (RRI), the Asia Pacific region scores 52.4 out of 100, comparing relatively well with Central and Eastern Europe (52.4), the Americas (50.5) and the Middle East and Africa (40.4) region but below Western Europe (70.6). The indicators used to assess the attractiveness of a pharmaceutical market are now visible, improving the transparency of the index system and enabling the identification of regional or group outperformers across single indicators. A market's RRI score is made up of a sum of the Rewards score (Industry Rewards + Country Rewards) and the Risks score (Industry Risks + Country Risks).

Table of Contents

BMI Industry View

  • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (Asia (Region) 2014-2020)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts ( Asia (Region) 2012-2020)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts ( Asia (Region) 2012-2020)

Industry Risk Reward Index

  • Asia Pacific Risk/Reward Index - Q4 2016

Market Overview

Industry Trends and Developments

  • Industry Trends And Developments

Regional Overview

  • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (2012-2020)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top